József Erfán

9.6k total citations · 1 hit paper
6 papers, 2.6k citations indexed

About

József Erfán is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Otorhinolaryngology. According to data from OpenAlex, József Erfán has authored 6 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Molecular Biology and 3 papers in Otorhinolaryngology. Recurrent topics in József Erfán's work include Lung Cancer Treatments and Mutations (3 papers), Head and Neck Cancer Studies (3 papers) and Protein Degradation and Inhibitors (2 papers). József Erfán is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Head and Neck Cancer Studies (3 papers) and Protein Degradation and Inhibitors (2 papers). József Erfán collaborates with scholars based in Hungary, France and Germany. József Erfán's co-authors include Ricard Mesı́a, Frédéric Peyrade, Éva Remenár, Carsten Bokemeyer, Ricardo Hitt, Sylvie Rottey, Nadia Amellal, Andrzej Kawecki, Didier Cupissol and Armin Schueler and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Acta Oto-Laryngologica.

In The Last Decade

József Erfán

6 papers receiving 2.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

2008 2.6k citations Jan B. Vermorken, Ricard Mesı́a et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
József Erfán Hungary	5	1.5k	1.4k	1.2k	769	614	6	2.6k
Andrzej Kawecki Poland	11	1.8k 1.2×	1.6k 1.2×	1.4k 1.2×	923 1.2×	717 1.2×	46	3.1k
Marco Benasso Italy	16	2.0k 1.3×	2.1k 1.5×	1.6k 1.4×	1.2k 1.6×	759 1.2×	67	3.7k
D. De Raucourt France	22	2.2k 1.4×	2.8k 2.0×	1.9k 1.6×	1.9k 2.4×	787 1.3×	55	4.4k
A. Trotti United States	7	709 0.5×	1.4k 1.0×	637 0.6×	918 1.2×	491 0.8×	15	2.2k
Carla van Herpen Netherlands	13	834 0.5×	979 0.7×	606 0.5×	864 1.1×	459 0.7×	29	1.9k
Éva Remenár Hungary	21	2.7k 1.7×	2.9k 2.1×	2.0k 1.7×	1.8k 2.4×	1.1k 1.8×	64	5.0k
Pol Specenier Belgium	21	1.1k 0.7×	450 0.3×	542 0.5×	287 0.4×	624 1.0×	84	1.9k
Christian Borel France	23	1.2k 0.8×	386 0.3×	496 0.4×	433 0.6×	348 0.6×	78	1.9k
Sandra Schmitz Belgium	21	614 0.4×	483 0.3×	385 0.3×	504 0.7×	389 0.6×	67	1.4k
Ammar Sukari United States	24	1.5k 1.0×	372 0.3×	635 0.5×	311 0.4×	640 1.0×	118	2.3k

Countries citing papers authored by József Erfán

Since Specialization

Citations

This map shows the geographic impact of József Erfán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by József Erfán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites József Erfán more than expected).

Fields of papers citing papers by József Erfán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by József Erfán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by József Erfán. The network helps show where József Erfán may publish in the future.

Co-authorship network of co-authors of József Erfán

This figure shows the co-authorship network connecting the top 25 collaborators of József Erfán. A scholar is included among the top collaborators of József Erfán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with József Erfán. József Erfán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Soulières, Denis, Sandrine Faivre, Ricard Mesı́a, et al.. (2016). BERIL-1: A phase II, placebo-controlled study of buparlisib (BKM120) plus paclitaxel in patients with platinum-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 34(15_suppl). 6008–6008. 11 indexed citations

2.

Dank, Magdolna, Béla Pikó, László Mangel, et al.. (2014). First-line bevacizumab-paclitaxel in 220 patients with metastatic breast cancer: results from the AVAREG study.. PubMed. 34(3). 1275–80. 11 indexed citations

3.

Vermorken, Jan B., Frédéric Peyrade, Juergen Krauss, et al.. (2012). Cilengitide with cetuximab, cisplatin, and 5-FU in recurrent and/or metastatic squamous cell cancer of the head and neck: The ADVANTAGE phase II trial.. Journal of Clinical Oncology. 30(15_suppl). 5516–5516. 6 indexed citations

4.

Vermorken, Jan B., Ricard Mesı́a, Fernando Rivera, et al.. (2008). Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer. New England Journal of Medicine. 359(11). 1116–1127. 2594 indexed citations breakdown →

5.

Erfán, József, et al.. (2005). Familial clustering of nasopharyngeal carcinoma in a non-endemic geographical region. Report of two Hungarian cases and a review of the literature. Acta Oto-Laryngologica. 125(9). 1008–1013. 7 indexed citations

6.

Erfán, József, et al.. (2005). The state of Hungarian radiotherapy. Reports of Practical Oncology & Radiotherapy. 10(4). 209–216. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact